Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.26B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.29B |
| 3 |
Eli Lilly
LLY
|
+$1.06B |
| 4 |
NVIDIA
NVDA
|
+$588M |
| 5 |
Meta Platforms (Facebook)
META
|
+$462M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$654M |
| 2 |
Apple
AAPL
|
+$459M |
| 3 |
Iris Energy
IREN
|
+$384M |
| 4 |
Micron Technology
MU
|
+$349M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$307M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.22% |
| 2 | Financials | 7.89% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.33% |
| 5 | Consumer Discretionary | 4.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Ethan Allen Interiors
ETD
$603M
| $2.77M | ﹤0.01% |
121,160
+3,380
| +3% | +$84.3K |
|
|
JPUS
3102
JPMorgan Diversified Return US Equity ETF
JPUS
$465M
| $2.77M | ﹤0.01% |
22,321
-480
| -2% | -$59.3K |
|
3103
Galicia Financial Group
GGAL
$7.42B
| $2.76M | ﹤0.01% |
51,242
+50,097
| +4,375% | +$2.34M |
|
3104
Chemours
CC
$2.37B
| $2.75M | ﹤0.01% |
233,614
+69,421
| +42% | +$891K |
|
3105
Crescent Capital BDC
CCAP
$434M
| $2.75M | ﹤0.01% |
195,794
-62,770
| -24% | -$892K |
|
3106
Levi Strauss
LEVI
$9.39B
| $2.74M | ﹤0.01% |
132,304
+465
| +0.4% | +$10K |
|
|
BKV
3107
BKV Corp
BKV
$2.68B
| $2.74M | ﹤0.01% |
100,902
+86,703
| +611% | +$2.18M |
|
|
WSR
3108
DELISTED
Whitestone REIT
WSR
| $2.73M | ﹤0.01% |
196,630
+15,984
| +9% | +$206K |
|
|
MCN
3109
Madison Covered Call & Equity Strategy Fund
MCN
$118M
| $2.71M | ﹤0.01% |
452,083
+5,773
| +1% | +$34.6K |
|
3110
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$295M
| $2.71M | ﹤0.01% |
55,127
+51,556
| +1,444% | +$2.56M |
|
|
ETW
3111
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $2.71M | ﹤0.01% |
293,744
-23,237
| -7% | -$211K |
|
3112
Photronics
PLAB
$1.93B
| $2.71M | ﹤0.01% |
84,613
+17,948
| +27% | +$463K |
|
3113
Spyre Therapeutics
SYRE
$9.25B
| $2.7M | ﹤0.01% |
82,416
+43,097
| +110% | +$1.13M |
|
3114
Harmony Gold Mining
HMY
$12.3B
| $2.7M | ﹤0.01% |
135,546
+38,482
| +40% | +$718K |
|
3115
Pacer Trendpilot US Bond ETF
PTBD
$86.1M
| $2.69M | ﹤0.01% |
138,873
-108,034
| -44% | -$2.12M |
|
3116
CALL
Keurig Dr Pepper
KDP
$40.8B
| $2.69M | ﹤0.01% |
96,100
| – | – |
|
3117
The GEO Group
GEO
$4.04B
| $2.69M | ﹤0.01% |
166,870
+66,543
| +66% | +$1.11M |
|
|
PPTA
3118
Perpetua Resources
PPTA
$3.09B
| $2.69M | ﹤0.01% |
111,029
+54,980
| +98% | +$1.35M |
|
3119
Myriad Genetics
MYGN
$312M
| $2.69M | ﹤0.01% |
437,034
-71,204
| -14% | -$516K |
|
3120
Innospec
IOSP
$2.28B
| $2.69M | ﹤0.01% |
35,091
+1,200
| +4% | +$90.6K |
|
3121
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $2.68M | ﹤0.01% |
53,853
+14,681
| +37% | +$677K |
|
3122
Immunocore
IMCR
$1.73B
| $2.68M | ﹤0.01% |
77,228
-6,453
| -8% | -$228K |
|
3123
Louisiana-Pacific
LPX
$5.49B
| $2.68M | ﹤0.01% |
33,166
-2,596
| -7% | -$219K |
|
|
HI
3124
DELISTED
Hillenbrand
HI
| $2.68M | ﹤0.01% |
84,376
+23,939
| +40% | +$738K |
|
3125
Erie Indemnity
ERIE
$13.2B
| $2.68M | ﹤0.01% |
9,333
+3,197
| +52% | +$954K |
|
Similar funds
Wells Fargo's Q4 2025 Portfolio in Review
As of Q4 2025, Wells Fargo held 7,429 positions worth $549B, up 4.4% from $526B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Wells Fargo's Q4 2025 filing shows 473 new, 3,755 increased, 1,877 reduced and 424 closed positions. Its largest new stake was Akre Focus ETF: 869,756 shares worth $57M. The largest sale was Advanced Micro Devices, an estimated $654M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q4 2025 buy was Akre Focus ETF: 869,756 shares worth $57M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $7.26B increase.
- Wells Fargo's biggest Q4 2025 reduction was Advanced Micro Devices, cutting an estimated $654M.
- Wells Fargo fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $51.6M.
- Wells Fargo's ten largest holdings make up 21% of its $549B portfolio in Q4 2025.
- Wells Fargo opened 473 new positions and closed 424 in Q4 2025.
- Wells Fargo's portfolio value rose 4.4% quarter-over-quarter to $549B.
Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.